Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miles P Davenport

Showing results (1-10 of 265) with videos related to

Pageof 27
Sort By:
Plos One|December 15, 2010
Vaccination-induced noncytolytic effects in the acute phase of SHIV infectionJanka Petravic, Miles P Davenport
Plos One|March 2, 2011
Simian-human immunodeficiency infection--is the course set in the acute phase?Janka Petravic, Miles P Davenport
Plos Pathogens|February 4, 2010
CD8+ T cell control of HIV--a known unknownMiles P Davenport, Janka Petravic
The Lancet. HIV|May 14, 2019
Moving the HIV vaccine field forward: concepts of protective immunityStephen J Kent, Miles P Davenport
Immunology and Cell Biology|March 12, 2008
Infectious diseases: too little, too late for tuberculosisJames A Triccas, Miles P Davenport
The Lancet. HIV|October 2, 2015
Tentative first steps to eradicate latent HIVStephen J Kent, Miles P Davenport
Current Opinion in Immunology|October 1, 2013
Immunogenetics and transplantationMiles P Davenport, Deborah K Dunn-Walters
Journal of Theoretical Biology|January 27, 2009
Low red cell production may protect against severe anemia during a malaria infection--insights from modelingDeborah Cromer, Jaroslav Stark, Miles P Davenport
Journal of Virology|June 24, 2011
APOBEC3 has not left an evolutionary footprint on the HIV-1 genomeDiako Ebrahimi, Firoz Anwar, Miles P Davenport
Retrovirology|December 22, 2012
APOBEC3G and APOBEC3F rarely co-mutate the same HIV genomeDiako Ebrahimi, Firoz Anwar, Miles P Davenport
Pageof 27

Showing results (1-10 of 265) with videos related to

Sort By:
Pageof 27
Plos One|December 15, 2010
Vaccination-induced noncytolytic effects in the acute phase of SHIV infectionJanka Petravic, Miles P Davenport
Plos One|March 2, 2011
Simian-human immunodeficiency infection--is the course set in the acute phase?Janka Petravic, Miles P Davenport
Plos Pathogens|February 4, 2010
CD8+ T cell control of HIV--a known unknownMiles P Davenport, Janka Petravic
The Lancet. HIV|May 14, 2019
Moving the HIV vaccine field forward: concepts of protective immunityStephen J Kent, Miles P Davenport
Immunology and Cell Biology|March 12, 2008
Infectious diseases: too little, too late for tuberculosisJames A Triccas, Miles P Davenport
The Lancet. HIV|October 2, 2015
Tentative first steps to eradicate latent HIVStephen J Kent, Miles P Davenport
Current Opinion in Immunology|October 1, 2013
Immunogenetics and transplantationMiles P Davenport, Deborah K Dunn-Walters
Journal of Theoretical Biology|January 27, 2009
Low red cell production may protect against severe anemia during a malaria infection--insights from modelingDeborah Cromer, Jaroslav Stark, Miles P Davenport
Journal of Virology|June 24, 2011
APOBEC3 has not left an evolutionary footprint on the HIV-1 genomeDiako Ebrahimi, Firoz Anwar, Miles P Davenport
Retrovirology|December 22, 2012
APOBEC3G and APOBEC3F rarely co-mutate the same HIV genomeDiako Ebrahimi, Firoz Anwar, Miles P Davenport
Pageof 27